Luteolin use in Integrated Stress Response: insight from a case of EIF2AK2-related dystonia

Key Points

• Luteolin administration improves symptoms linked to the integrated stress response, indicating its therapeutic effect.
• Key evidence shows notable symptom relief in the case study of EIF2AK2-related dystonia, with improved mobility metrics.
• Case analysis highlights the integrated stress response's role in the pathophysiology of EIF2AK2 dystonia, focusing on molecular interactions.
• Findings suggest that luteolin may offer a novel approach for managing symptoms in patients with EIF2AK2-related dystonia.